Targeted Deletion of Kynurenine 3-Monooxygenase in Mice: A NEW TOOL FOR STUDYING KYNURENINE PATHWAY METABOLISM IN PERIPHERY AND BRAIN - Test2 - elhamkhani - TriplyDB

Targeted Deletion of Kynurenine 3-Monooxygenase in Mice: A NEW TOOL FOR STUDYING KYNURENINE PATHWAY METABOLISM IN PERIPHERY AND BRAIN

Targeted Deletion of Kynurenine 3-Monooxygenase in Mice: A NEW TOOL FOR STUDYING KYNURENINE PATHWAY METABOLISM IN PERIPHERY AND BRAIN

http://www.wikidata.org/entity/Q29306917

about

Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's Disease Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation.Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects.Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis.Prenatal inhibition of the kynurenine pathway leads to structural changes in the hippocampus of adult rat offspring.Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2(+/-) mice, using liquid chromatography-tandem mass spectrometry.Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine Anthranilic Acid: A Potential Biomarker and Treatment Target for Schizophrenia Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1 Kynurenic acid, an aryl hydrocarbon receptor ligand, is elevated in serum of Zucker fatty rats.Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior.The kynurenine pathway and the brain: Challenges, controversies and promises.Kynurenines and Glutamate: Multiple Links and Therapeutic Implications.Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice.Imbalanced kynurenine pathway in schizophrenia.Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders.Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain.The Interactions Between Kynurenine, Folate, Methionine and Pteridine Pathways in Obesity.Sex Differences in Hippocampal Memory and Kynurenic Acid Formation Following Acute Sleep Deprivation in Rats.

P2860

Q26781849-2908B2A6-9819-4358-8A6C-41986CA87634 Q26782867-10861D41-15E5-4733-A23E-BB221A07E7F6 Q28270694-DB10761E-FA8D-4158-9841-05AB9F264B50 Q30839124-DD38453A-40CA-4820-9181-4B47B32E16B5 Q33583816-3E750083-2B6E-4196-A24E-A3402A5429A6 Q34508486-D25082A4-5B8A-4CC0-9239-12E9ED8457F8 Q35202246-DCF00B8E-2189-4F77-8B92-EEE5B63C2841 Q35892576-EC675BB1-3496-4301-9968-6A3EB1B047E3 Q36131465-4ADA813D-B9BF-4EC3-B7BB-67816292F43F Q36273903-455283B5-E296-4366-B769-44215C619728 Q36756944-DD5945C9-CB95-4CE1-B9CD-502D244F58D7 Q36853284-C8929DCE-0224-456F-B7C4-C6A40F3B86DC Q37326812-6D993281-9010-4FB5-88FA-242EF8A948CA Q38761405-54709A37-2656-41D8-9843-9965A5C53D8E Q38832497-7026EC76-7468-4281-B2E1-115F1F3D0A45 Q38861843-0C7D22D1-3A38-46A5-A22B-FE0EAEE02167 Q39130393-441FD486-4F7A-47E4-88A2-0E002E55942C Q39185463-5DEA6B22-CDE5-4E57-9AEB-4D89C821A27E Q42495952-7B34281D-BAB3-4D60-B539-B61EF5C28B0B Q42921229-0288365D-524F-40E9-A82A-F48F9F5A8180 Q46061752-8F7A4318-F5BC-4B54-BDA7-4C4B1951E52A Q47826628-162671F5-BC5A-4EBE-8C2B-F598526B49F5 Q47865416-987907C0-C37C-4324-9450-8766E281C041 Q55048569-2C3E9C0A-AD98-4E99-995F-60388E180C88

P2860

Targeted Deletion of Kynurenine 3-Monooxygenase in Mice: A NEW TOOL FOR STUDYING KYNURENINE PATHWAY METABOLISM IN PERIPHERY AND BRAIN

http://www.wikidata.org/entity/Q29306917

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Targeted Deletion of Kynurenin ...... ABOLISM IN PERIPHERY AND BRAIN

@ast

Targeted Deletion of Kynurenin ...... ABOLISM IN PERIPHERY AND BRAIN

@en

type

label

Targeted Deletion of Kynurenin ...... ABOLISM IN PERIPHERY AND BRAIN

@ast

Targeted Deletion of Kynurenin ...... ABOLISM IN PERIPHERY AND BRAIN

@en

prefLabel

Targeted Deletion of Kynurenin ...... ABOLISM IN PERIPHERY AND BRAIN

@ast

Targeted Deletion of Kynurenin ...... ABOLISM IN PERIPHERY AND BRAIN

@en

P1433

Q29306917-35CCA283-7F3D-4D3D-9246-2AD7BF3F28CC

P1476

Q29306917-C2EE35D9-3207-451A-B898-B0637DFA70DD

P2093

Q29306917-19CD23C0-B303-4F92-B78B-2636D0BBBF19

Q29306917-334217BB-85AF-46F9-86F1-AD51D87DD1F2

Q29306917-4877CACB-499D-4C5C-B354-D73267854A77

Q29306917-5B679EB5-0FB7-422C-A9C9-7170948D31AC

Q29306917-934CC94D-C035-4919-9B85-D9472DBB7E9E

Q29306917-97959899-929F-4528-B1D2-9C48A670CEB6

Q29306917-9B49AB2B-0A3E-44F2-9407-4B6B5C3446C4

Q29306917-BCDD3D3E-1259-4D0B-9442-D7A03741A8A2

P2860

Q29306917-03CACB4D-8465-4BA9-9ABA-B90E86E5B05D

Q29306917-04031E07-238E-4351-9431-36F7E84999E4

Q29306917-0DBEFDF9-1C29-4779-94E3-AA4143DF17FD

Q29306917-0F3D02FB-B25C-4BFA-878A-22C99D360F66

Q29306917-0F91B0DB-8329-4B4F-BAAB-0BE41CBF0B87

Q29306917-141A0552-7E2D-42F0-81D8-428835BA2D8B

Q29306917-18DA6332-679D-4E01-9FE8-C87A99247C4B

Q29306917-1D9AD400-52A3-4D16-B5E8-5E0302881F4D

Q29306917-1E896B22-81DF-4A82-A200-32CF07B93EFB

Q29306917-20643AAF-CD03-4AF9-B30C-571443317085

P304

Q29306917-27DFD7A9-6E40-44AB-BF77-5794E9E6CE4B

P31

Q29306917-4C4806A6-4A14-462B-A8E3-1C67B599D009

P3181

Q29306917-86F91219-12AE-482F-B597-779670ECB6CA

P356

Q29306917-610E4624-D151-4DC4-8180-C8BE5AD1FFB4

P407

Q29306917-C95873B4-B9C6-4EEF-9A91-D638DE0F9553

P433

Q29306917-586842C2-F0E9-4E7E-93D1-171AA714E851

P478

Q29306917-22BBCE6E-BBEF-4424-8D00-0FB5731C638D

P50

Q29306917-15A2E964-2236-40BA-A581-0681356E078E

P577

Q29306917-40D911B0-912D-4975-B302-49B23EC01639

P698

Q29306917-34D8388D-3E69-4541-BF1B-7CED298DFB34

P932

Q29306917-A942C683-C984-4035-84DA-72FCC9F3180D

P3181

P356

JBC.M113.503813

P1433

Journal of Biological Chemistry

P1476

Targeted deletion of kynurenin ...... abolism in periphery and brain

@en

P2093

Flaviano Giorgini

http://www.w3.org/2001/XMLSchema#string

Francesca M Notarangelo

http://www.w3.org/2001/XMLSchema#string

Hui-Qiu Wu

http://www.w3.org/2001/XMLSchema#string

Korrapati V Sathyasaikumar

http://www.w3.org/2001/XMLSchema#string

Marian A R Thomas

http://www.w3.org/2001/XMLSchema#string

Paul J Muchowski

http://www.w3.org/2001/XMLSchema#string

Robert Schwarcz

http://www.w3.org/2001/XMLSchema#string

Shao-Yi Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35

Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls

Kynurenine is an endothelium-derived relaxing factor produced during inflammation

Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.

Kynurenines in the mammalian brain: when physiology meets pathology

Structural basis of kynurenine 3-monooxygenase inhibition

A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease.

The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications

The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

P304

36554-36566

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3583012

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M113.503813

http://www.w3.org/2001/XMLSchema#string

P407

P433

51

http://www.w3.org/2001/XMLSchema#string

P478

288

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24189070

http://www.w3.org/2001/XMLSchema#string

P932

3868768

http://www.w3.org/2001/XMLSchema#string